2
Clinical Trials associated with MVA strain monkeypox live attenuated vaccine(Shanghai Institute of Biological Products)评估MVA株猴痘减毒活疫苗用于18岁及以上人群安全性和免疫原性的随机、双盲、安慰剂对照 Ⅰ 期临床试验
[Translation] A randomized, double-blind, placebo-controlled phase I clinical trial to evaluate the safety and immunogenicity of the live attenuated MVA monkeypox vaccine in people aged 18 years and above
评价18岁及以上人群中接种2剂MVA株猴痘减毒活疫苗的安全性和免疫原性。
[Translation] To evaluate the safety and immunogenicity of two doses of live attenuated monkeypox vaccine (MVA strain) in people aged 18 years and above.
/ Not yet recruitingPhase 1 A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial Evaluating the Safety and Immunogenicity of MVA Strain Monkeypox Attenuated Live Vaccine for Individuals Aged 18 and Above
This is a randomized, double blinded, controlled phase I clinical study. To evaluate the safety and immunogenicity of receiving two doses of MVA strain monkeypox attenuated live vaccine in individuals aged 18 years and above.
100 Clinical Results associated with MVA strain monkeypox live attenuated vaccine(Shanghai Institute of Biological Products)
100 Translational Medicine associated with MVA strain monkeypox live attenuated vaccine(Shanghai Institute of Biological Products)
100 Patents (Medical) associated with MVA strain monkeypox live attenuated vaccine(Shanghai Institute of Biological Products)
100 Deals associated with MVA strain monkeypox live attenuated vaccine(Shanghai Institute of Biological Products)